BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12522043)

  • 1. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.
    Gärtner BC; Hess RD; Bandt D; Kruse A; Rethwilm A; Roemer K; Mueller-Lantzsch N
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):78-82. PubMed ID: 12522043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I; Giménez E; Navarro D
    Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
    Appak O; Ozkaratas MH; Sayiner AA
    J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections.
    de Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Clin Vaccine Immunol; 2011 Mar; 18(3):444-8. PubMed ID: 21191077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.
    Klutts JS; Liao RS; Dunne WM; Gronowski AM
    J Clin Microbiol; 2004 Nov; 42(11):4996-5000. PubMed ID: 15528686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.
    Park Y; Park BG; Ha J; Kim HS
    Ann Lab Med; 2018 Sep; 38(5):458-465. PubMed ID: 29797817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel.
    Schulte-Spechtel U; Berth M; Lauseker-Hao Y; Meyer-Schlinkmann K; Bohnert M; Jochum S; Schuhmann K
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115443. PubMed ID: 34304105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus.
    Weber B; Brunner M; Preiser W; Doerr HW
    J Virol Methods; 1996 Mar; 57(1):87-93. PubMed ID: 8919826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Abbott Architect
    François C; Segard C; Bouvier M; Stefanski M; Pannier C; Zawadzki P; Roussel C; Hecquet D; Duverlie G; Brochot E; Castelain S
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):96-101. PubMed ID: 29198371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein-Barr virus infection.
    Debyser Z; Reynders M; Goubau P; Desmyter J
    Clin Diagn Virol; 1997 May; 8(1):71-81. PubMed ID: 9248660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies.
    Bruu AL; Hjetland R; Holter E; Mortensen L; Natås O; Petterson W; Skar AG; Skarpaas T; Tjade T; Asjø B
    Clin Diagn Lab Immunol; 2000 May; 7(3):451-6. PubMed ID: 10799460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
    Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
    Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis.
    Linde A; Kallin B; Dillner J; Andersson J; Jägdahl L; Lindvall A; Wahren B
    J Infect Dis; 1990 May; 161(5):903-9. PubMed ID: 2157771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.